We are live on
!
Find out more
LSV Asset Management Portfolio holdings
AUM
$55.1B
1-Year Est. Return
45.38%
This Fund
S&P 500
This Quarter
Est. Return
+4.98%
1 Year Est. Return
+45.38%
3 Year Est. Return
+99.45%
5 Year Est. Return
+122.42%
10 Year Est. Return
+379.58%
AUM
$45.4B
AUM Growth
+$767M
(+1.7%)
Cap. Flow
-$656M
Cap. Flow
% of AUM
-1.45%
Top 10 Holdings %
Top 10 Hldgs %
13.02%
Holding
941
New
55
Increased
254
Reduced
363
Closed
43
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Centene
CNC
|
+$138M |
| 2 |
Skyworks Solutions
SWKS
|
+$134M |
| 3 |
SF
Stifel
SF
|
+$116M |
| 4 |
Capri Holdings
CPRI
|
+$97.6M |
| 5 |
Comcast
CMCSA
|
+$97.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Intel
INTC
|
+$281M |
| 2 |
J.M. Smucker
SJM
|
+$152M |
| 3 |
TRTN
Triton International Limited
TRTN
|
+$139M |
| 4 |
Seagate
STX
|
+$107M |
| 5 |
Pfizer
PFE
|
+$105M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 18.69% |
| 2 | Healthcare | 15.44% |
| 3 | Technology | 15.26% |
| 4 | Consumer Discretionary | 13.94% |
| 5 | Industrials | 11.09% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
Merck
MRK
$369B
| $980M | 2.16% |
8,495,450
-681,670
| -7% | -$77.4M |
|
2
ExxonMobil
XOM
$643B
| $643M | 1.42% |
5,993,697
-397,370
| -6% | -$43.4M |
|
3
Cisco
CSCO
$442B
| $603M | 1.33% |
11,659,735
+580,820
| +5% | +$28.6M |
|
4
Bristol-Myers Squibb
BMY
$137B
| $601M | 1.33% |
9,398,655
-2,781
| -0% | -$186K |
|
|
5
Comcast
CMCSA
$93.7B
| $600M | 1.32% |
14,433,200
+2,448,459
| +20% | +$97.2M |
|
|
6
Pfizer
PFE
$160B
| $535M | 1.18% |
14,593,768
-2,693,950
| -16% | -$105M |
|
7
Verizon
VZ
$205B
| $528M | 1.16% |
14,205,207
-378,900
| -3% | -$14M |
|
8
Gilead Sciences
GILD
$185B
| $485M | 1.07% |
6,292,469
-192,260
| -3% | -$15.3M |
|
9
Kroger
KR
$34.9B
| $470M | 1.04% |
9,991,372
-201,140
| -2% | -$9.59M |
|
10
AT&T
T
$174B
| $460M | 1.01% |
28,842,643
-605,700
| -2% | -$10.3M |
|
11
Molson Coors Class B
TAP
$7.77B
| $460M | 1.01% |
6,982,562
-410,800
| -6% | -$25.4M |
|
12
Amgen
AMGN
$236B
| $451M | 0.99% |
2,031,018
-84,300
| -4% | -$19.6M |
|
13
AGCO
AGCO
$7.77B
| $436M | 0.96% |
3,318,770
+140,652
| +4% | +$17.4M |
|
14
Jabil
JBL
$32.7B
| $435M | 0.96% |
4,026,017
+221,458
| +6% | +$19.5M |
|
15
Oracle
ORCL
$438B
| $433M | 0.95% |
3,633,088
-202,652
| -5% | -$21M |
|
16
Ameriprise Financial
AMP
$49.1B
| $422M | 0.93% |
1,271,193
-21,850
| -2% | -$6.72M |
|
17
Meta Platforms (Facebook)
META
$1.45T
| $411M | 0.91% |
1,433,220
-36,690
| -2% | -$9.05M |
|
18
McKesson
MCK
$104B
| $409M | 0.9% |
957,667
-61,277
| -6% | -$23.6M |
|
19
CVS Health
CVS
$119B
| $399M | 0.88% |
5,769,291
+24,247
| +0.4% | +$1.73M |
|
20
HP
HPQ
$27.1B
| $394M | 0.87% |
12,844,710
-358,960
| -3% | -$10.8M |
|
21
Cummins
CMI
$79B
| $389M | 0.86% |
1,586,671
-32,710
| -2% | -$7.41M |
|
22
FedEx
FDX
$78.4B
| $377M | 0.83% |
1,521,580
+15,480
| +1% | +$3.54M |
|
23
Arrow Electronics
ARW
$10.6B
| $375M | 0.83% |
2,619,944
-56,874
| -2% | -$7.08M |
|
24
Citigroup
C
$223B
| $361M | 0.8% |
7,851,721
-152,630
| -2% | -$7.15M |
|
25
Aflac
AFL
$58.4B
| $356M | 0.78% |
5,095,034
-304,360
| -6% | -$20.4M |
|
Similar funds
HF
LSV Asset Management's Q2 2023 Portfolio in Review
As of Q2 2023, LSV Asset Management held 941 positions worth $45.4B, up 1.7% from $44.6B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
LSV Asset Management's Q2 2023 filing shows 55 new, 254 increased, 363 reduced and 43 closed positions. Its largest new stake was Global Payments: 464,480 shares worth $45.8M. The largest sale was Intel, an estimated $281M.
By sector, the portfolio is most concentrated in Financials at 19% of assets, up from 18% a quarter earlier, followed by Healthcare and Technology.
- LSV Asset Management's largest Q2 2023 buy was Global Payments: 464,480 shares worth $45.8M.
- LSV Asset Management added most to Centene in Q2 2023, an estimated $138M increase.
- LSV Asset Management's biggest Q2 2023 reduction was Intel, cutting an estimated $281M.
- LSV Asset Management fully exited Regeneron Pharmaceuticals in Q2 2023, selling an estimated $40.6M.
- LSV Asset Management's ten largest holdings make up 13% of its $45.4B portfolio in Q2 2023.
- LSV Asset Management opened 55 new positions and closed 43 in Q2 2023.
- LSV Asset Management's portfolio value rose 1.7% quarter-over-quarter to $45.4B.
Based on LSV Asset Management's 13F filing for Q2 2023, filed 2 Aug 2023.